Jefferies Group LLC Tyme Technologies, Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020
SELL
$1.0 - $1.49 $23,972 - $35,718
-23,972 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$0.97 - $1.77 $23,252 - $42,430
23,972 New
23,972 $29,000
Q3 2018

Nov 14, 2018
SELL
$2.18 - $3.44 $305,200 - $481,600
-140,000 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$2.05 - $4.09 $203,359 - $405,728
99,200 Added 243.14%
140,000 $442,000
Q1 2018

May 15, 2018
BUY
$2.12 - $7.0 $86,496 - $285,600
40,800 New
40,800 $91,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email